245 related articles for article (PubMed ID: 34307658)
1. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
Nesic M; Bødker JS; Terp SK; Dybkær K
Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.
Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA
Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317
[No Abstract] [Full Text] [Related]
3. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
Wang M; Huang X; Li X; Guo Q; Xu W; Zhao M; Wang X; Wang L; Lou J
Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
[TBL] [Abstract][Full Text] [Related]
4. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
[TBL] [Abstract][Full Text] [Related]
5. Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine.
Murugesan K; Hogan CA; Palmer Z; Reeve B; Theron G; Andama A; Somoskovi A; Steadman A; Madan D; Andrews J; Croda J; Sahoo MK; Cattamanchi A; Pinsky BA; Banaei N
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511335
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
7. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
[TBL] [Abstract][Full Text] [Related]
8. Performance comparison of blood collection tubes as liquid biopsy storage system for minimizing cfDNA contamination from genomic DNA.
Zhao Y; Li Y; Chen P; Li S; Luo J; Xia H
J Clin Lab Anal; 2019 Feb; 33(2):e22670. PubMed ID: 30191594
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma.
Warton K; Yuwono NL; Cowley MJ; McCabe MJ; So A; Ford CE
Mol Diagn Ther; 2017 Oct; 21(5):563-570. PubMed ID: 28631163
[TBL] [Abstract][Full Text] [Related]
10. Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.
Medina Diaz I; Nocon A; Mehnert DH; Fredebohm J; Diehl F; Holtrup F
PLoS One; 2016; 11(11):e0166354. PubMed ID: 27832189
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
12. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies.
Ward Gahlawat A; Lenhardt J; Witte T; Keitel D; Kaufhold A; Maass KK; Pajtler KW; Sohn C; Schott S
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736351
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
[TBL] [Abstract][Full Text] [Related]
15. Performance of ImproGene cfDNA blood collection tubes for mutation analysis in cancer patients.
Zhang S; Zhou D; Li S; Bai Y; Huang B; Han J; Xu M; Wang S; Deng G
Scand J Clin Lab Invest; 2022 Sep; 82(5):378-384. PubMed ID: 35861435
[TBL] [Abstract][Full Text] [Related]
16. Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
van Dessel LF; Beije N; Helmijr JC; Vitale SR; Kraan J; Look MP; de Wit R; Sleijfer S; Jansen MP; Martens JW; Lolkema MP
Mol Oncol; 2017 Mar; 11(3):295-304. PubMed ID: 28164427
[TBL] [Abstract][Full Text] [Related]
17. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pre-analytical factors affecting plasma DNA analysis.
Markus H; Contente-Cuomo T; Farooq M; Liang WS; Borad MJ; Sivakumar S; Gollins S; Tran NL; Dhruv HD; Berens ME; Bryce A; Sekulic A; Ribas A; Trent JM; LoRusso PM; Murtaza M
Sci Rep; 2018 May; 8(1):7375. PubMed ID: 29743667
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral blood.
Pandoh PK; Corbett RD; McDonald H; Alcaide M; Kirk H; Trinh E; Haile S; MacLeod T; Smailus D; Bilobram S; Mungall AJ; Ma Y; Moore RA; Coope R; Zhao Y; Jones SJ; Holt RA; Karsan A; Morin RD; Marra MA
Biotechniques; 2019 Feb; 66(2):85-92. PubMed ID: 30744412
[TBL] [Abstract][Full Text] [Related]
20. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.
Braig D; Becherer C; Bickert C; Braig M; Claus R; Eisenhardt AE; Heinz J; Scholber J; Herget GW; Bronsert P; Fricke A; Follo M; Stark GB; Bannasch H; Eisenhardt SU
Int J Cancer; 2019 Aug; 145(4):1148-1161. PubMed ID: 30779112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
